celecoxib has been researched along with lewis y antigen in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aziz, F; Wang, X; Yan, Q; Yang, X | 1 |
1 other study(ies) available for celecoxib and lewis y antigen
Article | Year |
---|---|
Anti-LeY antibody enhances therapeutic efficacy of celecoxib against gastric cancer by downregulation of MAPKs/COX-2 signaling pathway: correlation with clinical study.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cyclooxygenase 2; Down-Regulation; Drug Synergism; Helicobacter Infections; Helicobacter pylori; Humans; Lewis Blood Group Antigens; MAP Kinase Signaling System; Middle Aged; Pyrazoles; Signal Transduction; Stomach Neoplasms; Stomach Ulcer; Sulfonamides; Treatment Outcome; Tumor Cells, Cultured | 2015 |